TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy

European Journal of Endocrinology

Volumn 167, Issue 3, 2012, Pages 373-378

  Ito, Mitsuru ^a   Miyauchi, Akira ^a   Morita, Shinji ^a   Kudo, Takumi ^a   Nishihara, Eijun ^a   Kihara, Minoru ^a   Takamura, Yuuki ^a   Ito, Yasuhiro ^a   Kobayashi, Kaoru ^a   Miya, Akihiro ^a   Kubota, Sumihisa ^a   Amino, Nobuyuki ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 84865756960     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-1029     Document Type: Article

References (21)

1. Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F & Bianchi R. Thyroidal and peripheral production of 3,5,3′-triiodothyronine in humans by multicompartmental analysis. American Journal of Physiology 1990 258 715-726.
2. Bartalena L, Martino E, Pacchiarotti A, Grasso L, Aghini-Lombardi F, Buratti L, Bambini G, Breccia M & Pinchera A. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients. Journal of Clinical Endocrinology and Metabolism 1987 64 849-855. (doi:10.1210/jcem-64-4-849)
3. Burmeister LA, Goumaz MO, Mariash CN & Oppenheimer JH. Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism 1992 75 344-350. (doi:10.1210/jc.75.2.344)
4. Pearce CJ & Himsworth RL. Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine. BMJ 1984 288 693-695. (doi:10.1136/bmj.288.6418.693)
5. Liewendahl K, Helenius T, Lamberg BA, Mähönen H & Wägar G. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy. Acta Endocrinologica 1987 116 418-424. (doi:10.1530/acta.0.1160418)
6. Woeber KA. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. Journal of Endocrinological Investigation 2002 25 106-109.
7. Samuels MH, Schuff KG, Carlson NE, Carello P & Janowsky JS. Health status, psychological symptoms, mood, and cognition in L-thyroxine-treated hypothyroid subjects. Thyroid 2007 17 249-258. (doi:10.1089/thy.2006.0252)
8. Iverson JF & Mariash CN. Optimal free thyroxine levels for thyroid hormone replacement in hypothyroidism. Endocrine Practice 2008 14 550-555.
9. Jonklaas J, Davidson B, Bhagat S & Soldin SJ. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. Journal of the American Medical Association 2008 299 769-777. (doi:10.1001/jama.299.7.769)
10. Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G & Vigneri R. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS ONE 2011 6 e22552. (doi:10.1371/journal.pone.0022552)
11. Miyauchi A, Takamura Y, Ito Y, Miya A, Kobayashi K, Matsuzuka F, Amino N, Toyoda N, Nomura E & Nishikawa M. 3,5,3′-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2008 93 2239-2242. (doi:10.1210/jc.2007- 2282)
12. Alevizaki M, Mantzou E, Cimponeriu AT, Alevizaki CC & Koutras DA. TSH may not be a good marker for adequate thyroid hormone replacement therapy. Wiener Klinische Wochenschrift 2005 117 636-640. (doi:10.1007/s00508-005-0421-0)
13. Silva JE & Larsen PR. Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release. Journal of Clinical Investigation 1978 61 1247-1259. (doi:10.1172/JCI109041)
14. Hollenberg AN. Regulation of thyrotropin secretion. In The Thyroid, 9th edn, ch 10, pp 197-213. Eds LE Braverman & RD Utiger. Philadelphia: Lippincott Williams & Wirkins, 2005.
15. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R & Dayan CM. Psychologicalwell-being in patients on 'adequate' doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clinical Endocrinology 2002 57 577-585. (doi:10.1046/j.1365-2265.2002.01654.x)
16. Wekking EM, Appelhof BC, Fliers E, Schene AH, Huyser J, Tijssen JG & Wiersinga WM. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. European Journal of Endocrinology 2005 153 747-753. (doi:10.1530/eje.1.02025)
17. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS & Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Journal of the American Medical Association 2004 291 228-238. (doi:10.1001/jama.291.2.228)
18. Biondi B & Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews 2008 29 76-131. (doi:10.1210/er.2006- 0043)
19. Wennlund A. Variation in serum levels of T3, T4, FT4 and TSH during thyroxine replacement therapy. Acta Endocrinologica 1986 113 47-49. (doi:10.1530/acta.0.1130047)
20. Sturgess I, Thomas SH, Pennell DJ, Mitchell D & Croft DN. Diurnal variation in TSH and free thyroid hormones in patients on thyroxine replacement. Acta Endocrinologica 1989 121 674-676. (doi:10.1530/acta.0.1210674)
21. Escobar-Morreale HF, Obregón MJ, Escobar del Rey F & Morreale de Escobar G. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. Journal of Clinical Investigation 1995 96 2828-2838. (doi:10.1172/JCI118353)